Collectively, although the impact of GHSR deficiency was observed during the early stages of HFD administration, it did not significantly alter insulin secretion, glucose intolerance, nor insulin sensitivity in HFD-induced obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.